Quantcast
Connect with us

Trump’s top economic aide just made a stunning admission about the president’s dealings with China

Published

on

White House Director of Economic Policy Larry Kudlow made a stunning admission on Wednesday as he was discussing President Donald Trump’s trade negotiations with China.

Eamon Javers, a CNBC journalist covering the economy, reported on the remarks Kudlow made to a group of reporters. Kudlow said that Henry Kissinger, President Richard Nixon’s former secretary of State, had recently been to the White House — and he has also recently met with Chinese leader Xi Jinping twice.

ADVERTISEMENT

“I asked if Kissinger is playing a back channel role in trade talks,” Javers said.

“Well, now you’re getting into the family jewels,” Kudlow responded.

This alone is a jarring revelation. Kissinger has been persuasively accused of international war crimes as he has enabled dictators and mass atrocities abroad. Having ties to Kissinger, let alone having him actively work to shape policy, should be toxic for any sitting politician.

And then he went on:

ADVERTISEMENT

Of course, it’s no secret that Trump doesn’t care about human rights abuses in China — or anywhere. Nothing about his moves on foreign policy or his public statements have given any indication that he genuinely cares about countering authoritarian regimes, promoting democracy, or empowering the rights of minorities. And Trump openly embraces and lauds brutal rulers like Xi, Russia’s Vladimir Putin, and North Korea’s Kim Jong-un, while often spurning the leaders of democratic allies of the United States.

ADVERTISEMENT

But still, Kudlow’s caveat aside, it was remarkable for a top adviser to the president to admit on the record that the Chinese prefer Trump over Democrats because he doesn’t “go on about human rights and other things.”


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump’s health officials privately grumbling about his obsession with unproven anti-malaria drug for COVID-19: report

Published

on

On Monday, Politico reported that some health officials in the Trump administration are privately "unsettled" by the president's ongoing fascination with hydroxychloroquine, the drug primarily used to treat malaria, lupus, and arthritis that is now being suggested as a treatment for the novel coronavirus.

The president has repeatedly touted hydroxychloroquine as a possible miracle cure, and has even suggested he might start taking it himself, even though his tests for COVID-19 have been reported as negative and even though there's a lack of data that it is safe or effective for that purpose.

Continue Reading

Breaking Banner

Wisconsin GOP slammed for making people choose between their health and their vote

Published

on

After Republicans nationally and in Wisconsin successfully sued in both state and federal court to block voters from being given extra time and options to cast votes in the middle of a pandemic, commenters on social media reacted with fury.

What just happened re: Wisconsin can seem a bit confusing. The TL;DR: The Supreme Court decided that Republicans winning elections is more important than keeping voters healthy & alive.

Continue Reading
 

Breaking Banner

Watch how the BBC reports on ‘the reality’ in the United States during COVID-19 crisis

Published

on

The British Broadcasting Corporation is reporting on the "frantic and on-the-edge" situation in an intensive care unit in New York City.

The BBC had footage from CBS News, which was allowed in the ICU.

"Though the administration says there's no shortage of Personal Protective Equipment (PPE), the reality is otherwise," the BBC noted.

A front-line worker wearing a garbage bag "wished" she had the same PPE as the reporter.

"It's very, very difficult, it's like something out of 'The Twilight Zone,'" she said.

"And I don't think any of us going through it will ever be the same," she added.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image